Green Lifescience Co., Ltd. logo

Green Lifescience Co., Ltd. (114450)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
2,340. 00
+50
+2.1834%
57.26B Market Cap
- P/E Ratio
400% Div Yield
88,252 Volume
- Eps
2,290
Previous Close
Add Transaction
Day Range
2,250 2,360
Year Range
1,673 4,590
Want to track 114450 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

114450 closed today higher at ₩2,340, an increase of 2.1834% from yesterday's close, completing a monthly increase of 24.0721% or ₩454. Over the past 12 months, 114450 stock lost -21.7391%.
114450 pays dividends to its shareholders, with the most recent payment made on Jan 03, 2019.
Green Lifescience Co., Ltd. has completed 1 stock splits, with the recent split occurring on Sep 05, 2023.
The company's stock is traded on one exchange.

114450 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

Green Lifescience Co., Ltd. (114450) FAQ

What is the stock price today?

The current price is ₩2,340.00.

On which exchange is it traded?

Green Lifescience Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 114450.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 400%.

What is its market cap?

As of today, the market cap is 57.26B.

Has Green Lifescience Co., Ltd. ever had a stock split?

Green Lifescience Co., Ltd. had 1 splits and the recent split was on Sep 05, 2023.

Green Lifescience Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
5 Sep 2023 Last Split
- IPO Date

Overview

Green Lifescience Co., Ltd. positions itself as a highly dynamic entity within the biopharmaceutical realm, with its core objective centered around the innovation of healthcare solutions. The company is deeply ingrained in the field of research and development, focusing on the creation of novel diagnostic instruments, therapeutic biologics, and pharmaceutical products designed to meet critical healthcare needs. By pioneering new treatments and integrating technology into healthcare, Green Lifescience is making substantial contributions to the evolution of the healthcare industry. The company's activities are backed by in-depth scientific research and the diligent conduct of clinical trials. Operating globally, Green Lifescience supplies health professionals and institutions with superior products that significantly enhance patient care. In the financial sphere, the company is recognized for its substantial contributions to the advancement of life sciences, a factor that is crucial for the growth of related sectors such as biotechnology and pharmaceuticals.

Products and Services

Green Lifescience Co., Ltd. offers a diverse array of products and services, which include:

  • Diagnostic Tools: These are cutting-edge tools designed for the early detection and monitoring of diseases. By utilizing the latest in diagnostic technology, Green Lifescience aids healthcare professionals in making accurate diagnoses, thereby enabling the administration of timely and appropriate treatments.
  • Therapeutic Biologics: This category involves the development of biological products, such as vaccines, blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. These products are used in the treatment, prevention, or diagnosis of diseases and are derived from natural sources, modified in the lab for use in humans.
  • Pharmaceutical Products: Green Lifescience is also involved in the development and distribution of pharmaceutical drugs intended to cure, treat, or prevent diseases. These products are carefully developed following rigorous research, development processes, and clinical trials to ensure their efficacy and safety.

Contact Information

Address: -
Phone: -